Sitting Interruption and Whole-body Cardiovascular Health

NCT05316571 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2026-03-16

No results posted yet for this study

Summary

There is strong evidence for the association between sedentary behaviors and cardiovascular diseases such as coronary heart disease and stroke. However, the public currently has no clear guidance on how to limit or interrupt their sedentary behaviors. This study will identify and test the physiological effects of several sedentary behavior interruption strategies and explore the feasibility (i.e., likelihood of an individual performing the requested activities) of those strategies to inform the development of public policy surrounding sedentary behavior interruption. Long-term, the findings of this study will inform a large clinical trial that can test whether sedentary behavior reduction can decrease cardiovascular disease risk.

Conditions

  • Sedentary Behavior
  • Sedentary Time

Interventions

BEHAVIORAL

One 5-Minute Walking Bout Each Hour

One 5-minute light intensity walking break per hour throughout the 4-hour SB condition

BEHAVIORAL

One 15-Minute Standing Bout Each Hour

One 15-minute standing break per hour throughout the 4-hour SB condition

BEHAVIORAL

One 5-Minute Walking Bout and One 15-Minute Standing Bout Each Hour

Two breaks per hour throughout the 4-hour SB condition, alternating between a 5-minute light intensity walking break and a 15-minute standing break

BEHAVIORAL

Uninterrupted Sitting

No breaks will be provided throughout the 4-hour SB condition. This will be used as the control condition

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Erik Hanson, PhD · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-15
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05316571 on ClinicalTrials.gov